Home › Bronchiolitis Obliterans Syndrome › North Carolina › Durham
Bronchiolitis Obliterans Syndrome clinical trials in Durham, NC
6 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
RecruitingPhase 3
- Duke Eye Center - Ophthalmology, Durham
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
RecruitingPhase 2
- Duke Cancer Center, Durham
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi away
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
RecruitingPhase 1
- Duke, Durham
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Duke University Hospital, Durham
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Tampa, FL6 studies
- Baldwin Park, CA6 studies
- Philadelphia, PA6 studies
- Washington, DC6 studies
- San Francisco, CA5 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.